Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Infectious Disease · Chagas Disease

Understanding Chagas Disease and Its Phases

At a Glance

Chagas disease often remains silent after the initial infection, but some people later develop heart or digestive problems. Regular checkups with an ECG and echocardiogram can detect heart changes early, and antiparasitic treatment may be appropriate based on age and health.

Being diagnosed with Chagas disease often feels like a shock, especially if you feel perfectly healthy today. It is a complex condition caused by the parasite Trypanosoma cruzi (T. cruzi), which can live in the body for decades without causing any symptoms [1].

For many, the diagnosis comes through a routine blood donation screen or a check-up, revealing an infection that may have happened 20 or 30 years ago. It is important to know that you cannot spread Chagas through casual contact like hugging, kissing, or sharing food [2]. This is a manageable condition, and a diagnosis is the first step toward the monitoring and care that protects your long-term health.

How the Infection Spreads

Chagas disease is most common in parts of Mexico, Central America, and South America, where the parasite is spread by triatomine insects, often called “kissing bugs” [3]. These insects typically live in the cracks of walls or roofs of houses made from mud, adobe, or straw [4].

Transmission usually happens in a few specific ways:

  • Vector-borne: The insect bites a person and then defecates (poops) near the bite. The parasite enters the body when the person accidentally rubs the feces into the bite wound, their eyes, or their mouth [2].
  • Congenital: A pregnant person can pass the infection to their baby during pregnancy or birth [5].
  • Oral: In some areas, the parasite can be swallowed if food or juice is contaminated with the insect’s feces [6].
  • Medical: Though rare due to modern screening, the parasite can be spread through blood transfusions or organ transplants [7].

Because of global migration, millions of people now live with Chagas in many countries, including the United States and Europe [3].

The Three Phases of Chagas

Chagas disease moves through distinct clinical stages. Understanding where you are in this timeline helps your medical team decide on the best monitoring plan.

1. The Acute Phase

This phase begins immediately after the parasite enters the body and lasts several weeks to a few months [1]. Most people never realize they are in this phase because symptoms are either non-existent or very mild, like a slight fever, fatigue, or a small swelling where the bug bit them. Because these feel like a common flu, the infection often goes unnoticed.

2. The Chronic Indeterminate (Silent) Phase

After the acute phase, the body enters a “clinically silent” period. During this time:

  • The parasite is present in the body, and blood tests will show you are “positive” [1].
  • You have no symptoms and feel completely normal.
  • More than half of all people with Chagas will remain in this silent phase for the rest of their lives and will never develop serious heart or digestive problems [8].

3. The Chronic Determinate Phase

For about 20% to 30% of people, the disease may eventually cause damage to internal organs, usually over a period of years or decades [9][1].

  • Cardiac Form: This is Chagas cardiomyopathy, where the heart muscle becomes weak or enlarged, making it harder to pump blood [10].
  • Digestive Form: A smaller number of people may develop digestive issues, such as a severely enlarged esophagus or colon, which can make swallowing or bowel movements difficult [11].

Monitoring and Empowerment

A diagnosis does not mean you will definitely get sick. However, it does mean you need regular check-ups to catch any changes early, when they are most treatable. Current medical guidelines recommend a baseline evaluation that includes:

  • Electrocardiogram (ECG): A simple test to check the electrical activity and rhythm of your heart [12].
  • Echocardiogram: An ultrasound of the heart to look at its structure and how well it is pumping [10].

Research shows that for patients in the silent phase, the risk of developing heart problems is relatively low—roughly 1.3% to 1.9% per year, though this varies by age, sex, and geography [13][14]. By staying consistent with your doctor visits, you can ensure that if the disease ever begins to progress, you can start treatments to support your heart health immediately.

Coping with the Diagnosis

It is normal to feel overwhelmed, anxious, or even a sense of stigma after a Chagas diagnosis [15]. Many patients worry about how they got it or what it means for their family.

  • It is not your fault: Exposure often happened in childhood or during travel to rural areas years ago [2].
  • Family testing: Because the infection is not passed casually, you do not need to test everyone you know. However, doctors recommend testing children born to an infected mother to check for congenital transmission. Siblings may also warrant testing because they likely shared the same endemic housing or travel history [16].
  • Treatment is available: There are medications (benznidazole or nifurtimox) that can kill the parasite, especially in younger patients or those recently infected [17]. Your doctor will discuss if these are right for you based on your age and health status.

Knowledge is your best tool. By understanding the phases of the disease and committing to regular heart monitoring, you can take control of your health and live a full, active life.

Common questions in this guide

What are the different phases of Chagas disease?
Chagas disease usually begins with an acute phase lasting several weeks to a few months, followed by a chronic indeterminate phase in which blood tests remain positive but symptoms are absent. Some people later enter a chronic determinate phase affecting the heart or digestive tract, while more than half remain free of serious organ disease.
Can Chagas disease lead to cardiomyopathy?
Yes. In the chronic determinate phase, Chagas cardiomyopathy can weaken or enlarge the heart and make it harder to pump blood. Not everyone with Chagas develops heart disease, so regular follow-up can help detect changes early.
Which heart tests are used after a Chagas diagnosis?
A baseline 12-lead electrocardiogram, or ECG, checks the heart’s electrical activity and rhythm. An echocardiogram uses ultrasound to assess the heart’s structure and pumping function, and your clinician can decide when to repeat these tests.
Can I spread Chagas disease through hugging, kissing, or sharing food?
No. Chagas disease is not spread through casual contact such as hugging, kissing, or sharing food. Children born to an infected mother should be tested, and siblings may also need testing if they shared exposure in an endemic setting.
Is there treatment for Chagas disease?
Yes. Benznidazole and nifurtimox are antiparasitic medicines that can kill the parasite, with treatment often offering the greatest benefit to younger people or those infected more recently. Whether treatment is appropriate depends on your age, health, disease phase, and clinician’s assessment, and these medicines can cause side effects.
How often should someone with silent Chagas disease have checkups?
People in the chronic indeterminate phase should have regular medical follow-up even when they feel well. The timing of ECGs, echocardiograms, and other evaluations is individualized based on age, health history, geography, and new symptoms or findings.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my diagnosis, do I need a baseline 12-lead ECG and an echocardiogram to check my heart health?
  2. 2.Based on my history, what is the most likely way I was exposed to the parasite?
  3. 3.Do any of my family members—especially my children or siblings—need to be tested based on shared exposure?
  4. 4.What specific findings would mean my disease is moving from the 'silent' phase to a determinate phase?
  5. 5.Am I a candidate for antiparasitic treatment, and what are the potential side effects?
  6. 6.How often should I come in for follow-up testing if I currently have no symptoms?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    American Trypanosomiasis (Chagas Disease).

    Echeverria LE, Morillo CA

    Infectious disease clinics of North America 2019; (33(1)):119-134 doi:10.1016/j.idc.2018.10.015.

    PMID: 30712757
  2. 2

    Low risk for locally acquired Chagas disease in California: A review of human cases and triatomine submissions, 2013-2023.

    Lund AJ, Metzger ME, Kramer VL, Kjemtrup AM

    PLoS neglected tropical diseases 2025; (19(4)):e0013036 doi:10.1371/journal.pntd.0013036.

    PMID: 40258046
  3. 3

    Trypanosoma cruzi infection-induced changes in cardiac microvascular endothelial cell morphology and function.

    Gisclair LN, Johnston DA

    Journal of medical microbiology 2025; (74(11)) doi:10.1099/jmm.0.002095.

    PMID: 41231529
  4. 4

    Analysis of over 1500 triatomine vectors from across the US, predominantly Texas, for Trypanosoma cruzi infection and discrete typing units.

    Curtis-Robles R, Auckland LD, Snowden KF, et al.

    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2018; (58()):171-180 doi:10.1016/j.meegid.2017.12.016.

    PMID: 29269323
  5. 5

    Trypanosoma cruzi infection in Latin American pregnant women living outside endemic countries and frequency of congenital transmission: a systematic review and meta-analysis.

    Colombo V, Giacomelli A, Casazza G, et al.

    Journal of travel medicine 2021; (28(1)) doi:10.1093/jtm/taaa170.

    PMID: 32946555
  6. 6

    Chagas Disease in Latin America and the United States: Factors Influencing Differences in Transmission Rates Among Differing Populations and Vectors.

    Klotz SA

    Insects 2025; (16(6)) doi:10.3390/insects16060570.

    PMID: 40559000
  7. 7

    Transplantation for chagas' disease: closing the knowledge gap.

    La Hoz RM

    Current opinion in infectious diseases 2022; (35(5)):397-403 doi:10.1097/QCO.0000000000000868.

    PMID: 35942849
  8. 8

    The Oxidative Stress and Chronic Inflammatory Process in Chagas Disease: Role of Exosomes and Contributing Genetic Factors.

    Maldonado E, Rojas DA, Urbina F, Solari A

    Oxidative medicine and cellular longevity 2021; (2021()):4993452 doi:10.1155/2021/4993452.

    PMID: 34976301
  9. 9

    Risk Factors for Progression to Chronic Chagas Cardiomyopathy: A Systematic Review and Meta-Analysis.

    Cutshaw MK, Sciaudone M, Bowman NM

    The American journal of tropical medicine and hygiene 2023; (108(4)):791-800 doi:10.4269/ajtmh.22-0630.

    PMID: 36848894
  10. 10

    Chagas cardiomyopathy.

    Nunes MCP, Ribeiro ALP, Dutra W, et al.

    Heart (British Cardiac Society) 2026; doi:10.1136/heartjnl-2025-326968.

    PMID: 42185038
  11. 11

    Radionuclide esophageal transit scintigraphy in chronic indeterminate and cardiac forms of Chagas disease.

    Dumont SM, Costa HS, Chaves AT, et al.

    Nuclear medicine communications 2020; (41(6)):510-516 doi:10.1097/MNM.0000000000001186.

    PMID: 32282632
  12. 12

    WHF Recommendations for the Use of Echocardiography in Chagas Disease.

    Ralston K, Zaidel E, Acquatella H, et al.

    Global heart 2023; (18(1)):27 doi:10.5334/gh.1207.

    PMID: 37305068
  13. 13

    Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease: A Systematic Review and Meta-analysis.

    Chadalawada S, Sillau S, Archuleta S, et al.

    JAMA network open 2020; (3(8)):e2015072 doi:10.1001/jamanetworkopen.2020.15072.

    PMID: 32865573
  14. 14

    Clinical Characteristics and Outcomes of Chagas Disease in the United States: A Multicenter Retrospective Analysis.

    Henao-Martínez AF, Olivo-Freites C, Higuita NIA, et al.

    The American journal of tropical medicine and hygiene 2023; (109(5)):1006-1011 doi:10.4269/ajtmh.23-0361.

    PMID: 37696508
  15. 15

    Social determinants in the access to health care for Chagas disease: A qualitative research on family life in the "Valle Alto" of Cochabamba, Bolivia.

    Jimeno I, Mendoza N, Zapana F, et al.

    PloS one 2021; (16(8)):e0255226 doi:10.1371/journal.pone.0255226.

    PMID: 34383775
  16. 16

    Recommendations for Screening and Diagnosis of Chagas Disease in the United States.

    Forsyth CJ, Manne-Goehler J, Bern C, et al.

    The Journal of infectious diseases 2022; (225(9)):1601-1610 doi:10.1093/infdis/jiab513.

    PMID: 34623435
  17. 17

    The efficacy and safety of benznidazole in adults with seropositive indeterminate form, Trypanosoma cruzi infection: a systematic review and meta-analysis.

    Trowell JW, Mitre E, Marcus R, et al.

    BMC infectious diseases 2025; (26(1)):154 doi:10.1186/s12879-025-12231-4.

    PMID: 41436958

This page is for informational purposes only and does not constitute medical advice. It explains Chagas disease phases and monitoring, but your infectious disease or cardiology clinician should determine testing, treatment, and follow-up for your situation.

Get notified when new evidence is published on Chagas cardiomyopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.